U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07790965) titled 'Study of a Phakic Implantable Collamer Lens (ICL)' on Aug. 22.
Brief Summary: A prospective, open-labeled, single-site study of a phakic implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Myopia
Astigmatism
Intervention:
DEVICE: Phakic Implantable Collamer Lens (ICL)
Diffractive Trifocal Phakic ICL
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Staar Surgical Company
Disclaimer: Curated by HT Syndication....